Leading health tech company announces new International Vice President and General Manager appointment
Omnicell, Inc (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that Sara Dalmasso has joined the company as Vice President and General Manager, International.
In her new role, Sara will be responsible for setting the vision and strategic direction for Omnicell’s overall international organisation. Sara holds an MsC in Management, International Business from ESSCA in France and Wright State University in Dayton, Ohio. She is also certified as a Lean Six Sigma Black Belt.
Bringing nearly 20 years of digital and healthcare experience, Sara joins Omnicell from GE Healthcare, where she most recently served as Vice President and General Manager, Digital Solutions, EMEA. During her tenure at GE, Sara redefined the organisation’s go-to-market strategy resulting in a revenue growth of 20% and margin growth of 50%. Her proven track record also includes:
- creating new value-added service offerings which increased revenue by 10%
- developing a software as a service (SaaS) business model
- establishing value proposition and commercial engine
- deploying Service Cloud as a Service CRM
- increasing the Net Promoter score by 15 points.
“I am delighted to have joined the Omnicell team and am looking forward to helping further shape the future direction of the business across its international markets. There have been some great successes already and now is the time to reinforce our expertise and credentials in the fields of advanced automation, data intelligence and expert services,” commented Sara.
“I firmly believe in Omnicell’s mission to be the clinician’s most trusted partner for medication management, never has it been more important to deliver the most compelling automation and services to accelerate pharmacy perfection. I will be striving for us to achieve this in our international markets alongside the wider Omnicell team and am looking forward to the successful future that lies ahead of us.”
Peter Kuipers, Executive Vice President and Chief Financial Officer at Omnicell commented: “We are delighted to welcome Sara to the Omnicell team. She brings with her a wealth of experience and expertise from the healthcare technology sector which will be of huge value to our international business. Her focus will be on building on the success we have already had in international markets to establish Omnicell as a leader in advanced automation, data intelligence, and expert services.”
Omnicell’s core ethos is to improve patient care across all healthcare settings. Its products and services fall into three distinct areas: adherence automation, pharmacy automation and supplies automation. These all underpin a core aim of reducing medication dispensing errors, improving patient safety, driving supplies efficiency and enabling medical professionals to spend more time on face-to-face patient care.
Following extensive growth in the sector, Omnicell’s products and services can now be found inside the hospital environment, including A&E, operating theatres, wards and pharmacies, as well as in community pharmacy, care facilities and the home.
Omnicell International currently operates direct in the UK, France, Germany and Australia. It also has distributor agreements in place for its products in a number of other regions including the Middle East, South America, Italy, Spain, Taiwan, and Singapore.
- Niamh Donnelly